Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ottawa Hospital Research Institute
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with either invasive breast or prostate cancer (stage I-IV)
Age ≥18 years
ECOG performance status ≤2
Scheduled to receive intravenous taxane-based chemotherapy for either adjuvant or metastatic disease
Participants need to have ability to complete questionnaires by themselves or with assistance and have the ability to provide informed written consent
You may not be if
Concurrent use of any agents to try to prevent or treat neuropathy or TAPS, including gabapentin, glutamine, vitamin B6, and vitamin E.
Pre-existing history of peripheral neuropathy greater than grade 1 NCI CTCAE version 4.0 from any cause (chemotherapy, diabetes, alcohol, toxin, hereditary, etc.) other medical conditions that would make study participation unreasonably hazardous
Uncontrolled diabetes
Medical or psychiatric illness that would interfere with patients' ability to complete the diary
Clareo Health | Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer
